Dermatological Drugs Market Size, Share & Trends Analysis Report By Indication (Acne, Psoriasis, Rosacea, Alopecia), By Region (North America, Europe, Asia Pacific, Central & South America, MEA), And Segment Forecasts, 2021 - 2028

Table of Contents

Chapter 1. Methodology and Scope
                1.1. Market Segmentation & Scope
                1.2. Market Definition
                1.3. Information Procurement
                    1.3.1. Purchased Database
                    1.3.2. Million Insights’ Internal Database
                    1.3.3. Secondary Sources & Third-Party Perspectives
                    1.3.4. Primary Research
                1.4. Information Analysis
                    1.4.1. Data Analysis Models
                1.5. Market Formulation & Data Visualization
                1.6. Data Validation & Publishing
Chapter 2. Executive Summary
                2.1. Market Outlook
                2.2. Indication Outlook
                2.3. Regional Outlook
                2.4. Competitive Insights
Chapter 3. Dermatological Drugs Market Variables, Trends & Scope
                3.1. Market Introduction
                3.2. Penetration & Growth Prospect Mapping
                3.3. Industry Value Chain Analysis
                    3.3.1. Sales/Retail Channel Analysis
                    3.3.2. Profit Margin Analysis
                3.4. Market Dynamics
                    3.4.1. Market Driver Analysis
                    3.4.2. Market Restraint Analysis
                    3.4.3. Industry Challenges
                    3.4.4. Industry Opportunities
                3.5. Business Environment Analysis
                    3.5.1. Industry Analysis - Porter’s
                        3.5.1.1. Supplier Power
                        3.5.1.2. Buyer Power
                        3.5.1.3. Substitution Threat
                        3.5.1.4. Threat from New Entrant
                        3.5.1.5. Competitive Rivalry
                3.6. Roadmap of Dermatological Drugs Market
                3.7. Market Entry Strategies
                3.8. Impact of COVID-19
Chapter 4. Consumer Behavior Analysis
                4.1. Consumer Trends and Preferences
                4.2. Factors Affecting Buying Decision
                4.3. Consumer Product Adoption
                4.4. Observations & Recommendations
Chapter 5. Dermatological Drugs Market: Indication Estimates & Trend Analysis
                5.1. Indication Movement Analysis & Market Share, 2020 & 2028
                5.2. Acne
                    5.2.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                5.3. Psoriasis
                    5.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                5.4. Rosacea
                    5.4.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                5.5. Alopecia
                    5.5.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                5.6. Others
                    5.6.1. Market estimates and forecast, 2017 - 2028 (USD Million)
Chapter 6. Dermatological Drugs Market: Regional Estimates & Trend Analysis
                6.1. Regional Movement Analysis & Market Share, 2020 & 2028
                6.2. North America
                    6.2.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                    6.2.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                    6.2.3. U.S.
                        6.2.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                        6.2.3.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                6.3. Europe
                    6.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                    6.3.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                    6.3.3. Germany
                        6.3.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                        6.3.3.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                    6.3.4. France
                        6.3.4.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                        6.3.4.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                    6.3.5. U.K.
                        6.3.5.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                        6.3.5.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                6.4. Asia Pacific
                    6.4.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                    6.4.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                    6.4.3. China
                        6.4.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                        6.4.3.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                    6.4.4. India
                        6.4.4.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                        6.4.4.2. Market estimates and forecast, by Indication2017 - 2028 (USD Million)
                6.5. Central & South America
                    6.5.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                    6.5.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                    6.5.3. Brazil
                        6.5.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                        6.5.3.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                6.6. Middle East & Africa
                    6.6.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                    6.6.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
                    6.6.3. South Africa
                        6.6.3.1. Market estimates and forecast, 2017 - 2028 (USD Million)
                        6.6.3.2. Market estimates and forecast, by Indication, 2017 - 2028 (USD Million)
Chapter 7. Competitive Analysis
                7.1. Key global players, recent developments & their impact on the industry
                7.2. Key Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
                7.3. Vendor Landscape
                    7.3.1. Key company market share analysis, 2020
Chapter 8. Company Profiles
                8.1. Novartis AG
                    8.1.1. Company Overview
                    8.1.2. Financial Performance
                    8.1.3. Product Benchmarking
                    8.1.4. Strategic Initiatives
                8.2. Amgen Inc.
                    8.2.1. Company Overview
                    8.2.2. Financial Performance
                    8.2.3. Product Benchmarking
                    8.2.4. Strategic Initiatives
                8.3. AbbVie Inc.
                    8.3.1. Company Overview
                    8.3.2. Financial Performance
                    8.3.3. Product Benchmarking
                    8.3.4. Strategic Initiatives
                8.4. Johnson & Johnson
                    8.4.1. Company Overview
                    8.4.2. Financial Performance
                    8.4.3. Product Benchmarking
                    8.4.4. Strategic Initiatives
                8.5. Leo Pharma A/S
                    8.5.1. Company Overview
                    8.5.2. Financial Performance
                    8.5.3. Product Benchmarking
                    8.5.4. Strategic Initiatives
                8.6. Eli Lilly And Company
                    8.6.1. Company Overview
                    8.6.2. Financial Performance
                    8.6.3. Product Benchmarking
                    8.6.4. Strategic Initiatives
                8.7. GlaxoSmithKline Plc
                    8.7.1. Company Overview
                    8.7.2. Financial Performance
                    8.7.3. Product Benchmarking
                    8.7.4. Strategic Initiatives
                8.8. AstraZeneca plc
                    8.8.1. Company Overview
                    8.8.2. Financial Performance
                    8.8.3. Product Benchmarking
                    8.8.4. Strategic Initiatives
                8.9. Pfizer Inc.
                    8.9.1. Company Overview
                    8.9.2. Financial Performance
                    8.9.3. Product Benchmarking
                    8.9.4. Strategic Initiatives
                8.10. Merck KGaA
                    8.10.1. Company Overview
                    8.10.2. Financial Performance
                    8.10.3. Product Benchmarking
                    8.10.4. Strategic Initiatives

List of Tables

1. Dermatological Drugs market - Key market driver analysis
2. Dermatological Drugs market - Key market restraint analysis
3. Global Dermatological Drugs market revenue estimates and forecast by Acne, from 2017 - 2028 (USD Million)
4. Global Dermatological Drugs market revenue estimates and forecast by Psoriasis, from 2017 - 2028 (USD Million)
5. Global Dermatological Drugs market revenue estimates and forecast by Rosacea, from 2017 - 2028 (USD Million)
6. Global Dermatological Drugs market revenue estimates and forecast by Alopecia, from 2017 - 2028 (USD Million)
7. Global Dermatological Drugs market revenue estimates and forecast by Others, from 2017 - 2028 (USD Million)
8. Global Dermatological Drugs market estimates and forecast, by region 2017 - 2028 (USD Million)
9. Global Dermatological Drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
10. North America Dermatological Drugs market estimates and forecast, 2017 - 2028 (USD Million)
11. North America Dermatological Drugs market revenue estimates and forecast, by Indication, 2017 - 2028 (USD Million)
12. U.S. Dermatological Drugs market estimates and forecast, 2017 - 2028 (USD Million)
13. U.S. Dermatological Drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
14. Europe Dermatological Drugs market estimates and forecast, 2017 - 2028 (USD Million)
15. Europe Dermatological Drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
16. Germany Dermatological Drugs market estimates and forecast, 2017 - 2028 (USD Million)
17. Germany Dermatological Drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
18. France Dermatological Drugs market estimates and forecast, 2017 - 2028 (USD Million)
19. France Dermatological Drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
20. U.K. Dermatological Drugs market estimates and forecast, 2017 - 2028 (USD Million)
21. U.K. Dermatological Drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
22. Asia Pacific Dermatological Drugs market estimates and forecast, 2017 - 2028 (USD Million)
23. Asia Pacific Dermatological Drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
24. China Dermatological Drugs market estimates and forecast, 2017 - 2028 (USD Million)
25. China Dermatological Drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
26. India Dermatological Drugs market estimates and forecast, 2017 - 2028 (USD Million)
27. India Dermatological Drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
28. Central & South America Dermatological Drugs market estimates and forecast, 2017 - 2028 (USD Million)
29. Central & South America Dermatological Drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
30. Brazil Dermatological Drugs market estimates and forecast, 2017 - 2028 (USD Million)
31. Brazil Dermatological Drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
32. Middle East & Africa Dermatological Drugs market estimates and forecast, 2017 - 2028 (USD Million)
33. Middle East & Africa Dermatological Drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
34. South Africa Dermatological Drugs market estimates and forecast, 2017 - 2028 (USD Million)
35. South Africa Dermatological Drugs market revenue estimates and forecast by Indication, 2017 - 2028 (USD Million)
36. Vendor landscape

List of Figures

1. Dermatological Drugs market snapshot
2. Dermatological Drugs market segmentation & scope
3. Dermatological Drugs market penetration & growth prospect mapping
4. Dermatological Drugs market value chain analysis
5. Dermatological Drugs market dynamics
6. Dermatological Drugs market Porter's analysis
7. Dermatological Drugs market: Indication movement analysis
8. Dermatological Drugs market: Regional movement analysis